Intra Cellular Therapies shares owned by Skandinaviska Enskilda Banken AB
Quarter-by-quarter ownership of Intra Cellular Therapies (ITCI) shares owned by Skandinaviska Enskilda Banken AB
from 13F filings
Historical chart of Skandinaviska Enskilda Banken AB investment in Intra Cellular Therapies
Tip: Access up to 7 years of quarterly data
All positions including Intra Cellular Therapies held by Skandinaviska Enskilda Banken AB consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Intra Cellular Therapies by Skandinaviska Enskilda Banken AB
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-09-30 | $21M | 404k | 52.08 |
| 2023-06-30 | $26M | 404k | 63.31 |
| 2023-03-31 | $15M | 268k | 54.11 |
| 2022-12-31 | $20M | 373k | 52.95 |
| 2022-09-30 | $18M | 384k | 46.50 |
| 2022-06-30 | $22M | 384k | 57.05 |
| 2022-03-31 | $24M | 392k | 61.16 |
| 2021-12-31 | $21M | 396k | 52.15 |
| 2021-09-30 | $11M | 293k | 37.22 |
| 2021-06-30 | $12M | 293k | 40.82 |
| 2021-03-31 | $874k | 26k | 33.98 |
More positions owned by Skandinaviska Enskilda Banken AB
View all positions for Skandinaviska Enskilda Banken AB